Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Braz. j. infect. dis ; 27(6): 103687, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1528088

ABSTRACT

Abstract Acinetobacter spp. are one of the main pathogens responsible for healthcare-associated infections and are associated with high rates of morbidity and mortality globally, mainly because of their high capacity to present and develop resistance to antimicrobials. To identify species of the Acinetobacter and their resistance profiles from samples collected from hospitalized patients, health professionals and hospital environmental sources in the intensive care units of different public reference hospitals in Porto Velho City, Rondônia, Western Brazilian Amazon. Isolates were identified using microbiological and molecular techniques. The antimicrobial susceptibility profile was determined by disk diffusion. A total of 201 Acinetobacter spp. isolates were identified, of which 47.3% originated from hospital structures, 46.8% from patients and 6% from healthcare professionals. A. baumannii and A. nosocomialis were the most prevalent, with frequency of 58.7% and 31.8%, respectively. Regarding the susceptibility profile, it was observed that 56.3% were classified as multidrug-resistant and 76.2% of the samples belonging to A. baumannii were resistant to carbapenems. In contrast, 96.9% were susceptible to polymyxin B and 91.3% to doxycycline. The data presented here can be used to guide and strengthen the control of multidrug-resistant infections caused by Acinetobacter spp., in addition to improving providing information from a traditionally unassisted region of Brazil.

2.
Chinese Journal of Laboratory Medicine ; (12): 169-173, 2022.
Article in Chinese | WPRIM | ID: wpr-934349

ABSTRACT

Objectives:To investigate the antibacterial effects of Acinetobacter baumannii on Acinetobacter SPP. Methods:A Acinetobacter baumannii strain named SL- A.baumannii that can inhibit other Acinetobacter baumannii strains was isolated from the bronchoalveolar lavage fluid of a critically infected patient in the department of neurology, Henan Provincial Hospital on December 10, 2020. To better understand this inhibition effect, the drug resistance, homology and protein fingerprint of the new Acinetobacter baumannii strain, along with 40 other Acinetobacter SPP isolates, were analyzed. Results:Multilocus sequence typing (MLST) revealed that a novel allele combination (gltA/gyrB/gdhB/recA/cpn60/gpi/rpoD) 33, 12, 40, 26, 48, 54, 5 was found in SL- A.baumannii, and ST-2442 was assigned by PubMLST (Oxford). Moreover, 36 isolates, including 30 Acinetobacter baumannii strains, 2 Acinetobacter lwoffii strains, 3 Acinetobacter pittii strains and 1 Acinetobacter ursingii strain, were inhibited by SL- A.baumannii, the inhibition rate was 90% (36/40). Among those strains, 18 (50%) were sensitive to all the antibacterial drugs; 16 (44.44%) showed multi-drug resistance(MDR), including 2 pan-drug resistance(PDR) and 11 extensive drug resistance (XDR) strains; the other 2 (5.56%) were only resistant to Trimethoprim/Sulfamethoxazole(SXT). Conclusion:The new sequence type (ST-2442) Acinetobacter baumannii isolate SL- A.baumannii (PubMLST/Acinetobacter baumannii isolates database/id: 6942) had shown a significantinhibitory effect on Acinetobacter SPP with different drug-resistant phenotypes.

3.
Acta bioquím. clín. latinoam ; 54(2): 145-150, jun. 2020. tab
Article in Spanish | LILACS | ID: biblio-1130589

ABSTRACT

Conocer el rol del medio ambiente es fundamental para evitar las infecciones intra-hospitalarias. Con ese objetivo, se planteó evaluar la prevalencia de contaminación ambiental por microorganismos multirresistentes (MMR) antes y después de la limpieza terminal de habitaciones de pacientes colonizados y establecer si la aparatología de uso común actuaba como reservorio de estos en la unidad de cuidados intensivos (UTI). Se obtuvieron muestras ambientales de las habitaciones, 48 h posteriores a la detección de colonización y luego de las limpiezas. Los resultados mostraron que luego de ambos procedimientos de limpieza se logró reducir de 28,2% a 2,6% la contaminación por Acinetobacter spp. multirresistente (AMR). También, se tomaron muestras de aparatología de uso común encontrándose entre 1,8 y 5,4% de contaminación por MMR. La limpieza y desinfección reducen significativamente la contaminación ambiental. Sin embargo, la colonización de equipos por MMR y el incumplimiento de precauciones universales representan una posibilidad de transmisión cruzada.


It is essential to understand the role of the environment in order to avoid intrahospital infections. To achieve this objective, this research proposes to assess the prevalence of the environmental contamination caused by multi-resistant microorganisms (MRM) before and after terminal disinfection in rooms with colonized patients, but also to establish whether the commonly used device acts as a reservoir of those micro-organisms in an intensive care unit (ICU). Environmental samples were obtained from the rooms, 48 hours after detecting colonization and also after the first and second final cleaning. The results showed that after both procedures, there was a reduction from 28.2% to 2.6% of contamination caused by multi-resistant Acinetobacter spp. (AMR). Samples from appliances and supplies were taken as well, in which case, between 1.8 and 5.4% of contamination levels induced by MMR were found. Cleaning and disinfecting significantly reduce environmental contamination. However, both MMR bacterial colonization and the lack of universal precautions enforcement represent a possibility of cross-transmission.


É essencial conhecer o papel do meio ambiente para evitar as infecções intra-hospitalares. Com esse objetivo, planejou-se avaliar a prevalência de contaminação ambiental por microorganismos multirresistentes (MMR) antes e depois da limpeza final dos quartos de pacientes colonizados e estabelecer se os aparelhos de uso comum atuavam como um reservatório deles na unidade de terapia intensiva (UTI). Obtiveram-se amostras ambientais dos quartos 48 horas após a detecção da colonização e logo após as limpezas finais. Os resultados mostraram que depois dos dois procedimentos de limpeza se obteve uma redução de 28,2% para 2,6% da contaminação por Acinetobacter spp. multirresistente (AMR). Foram obtidas também amostras de aparelhos de uso comum onde se encontraram entre 1,8% e 5,4% de contaminação por MMR. A limpeza e a desinfecção reduzem significativamente a contaminação ambiental. Contudo, a colonização de equipamentos por MMR e o não cumprimento de providências universais representam uma possibilidade de transmissão cruzada.


Subject(s)
Humans , Acinetobacter , Acinetobacter/pathogenicity , Disinfection , Environmental Pollution , Environmental Pollution/prevention & control , Housekeeping, Hospital , Housekeeping, Hospital/ethics , Intensive Care Units , Research , Role , Patients' Rooms , Environmental Monitoring/methods , Prevalence , Environment , Housekeeping, Hospital/standards , Infections , Methods
4.
Article | IMSEAR | ID: sea-215611

ABSTRACT

Acinetobacter is a complex genus, with multiple species. Acinetobacterspecies are the common etiology of nosocomial infections, principally nosocomial pneumonia catheter-associated bacteremia and urinary tract infections. Multidrug Resistant (MDR) Ventilator Associated Pneumonia (VAP) by Acinetobacter spp is increasingly reported from different parts of the world. Transmission of Acinetobacter is aid by the organism's environmental stubbornness, resistance to desiccation and evasion of host immunity. The virulence properties demonstrated by Acinetobacter spp. is primarily by evasion of rapid clearance by the immune system. The capsular polysaccharide is a critical virulence factor that enables immune evasion and lipopolysaccharide triggers septic shock. Conversely, the primary factor of clinical outcome is antibiotic resistance. Acinetobacter spp. has become a discreditable threat for patients on mechanical ventilation. Considering high rate of antibiotic resistance, new preventive and therapeutic alternative pproach for MDR Acinetobacter spp. infections are urgently needed. Worldwide drug esistance in Acinetobacter baumannii is growing. This review article is emphasised on incidence of VAPdue to MDR Acinetobacter, phenotypes, genotypes, associated risk factors and preventive strategy

5.
Article | IMSEAR | ID: sea-203326

ABSTRACT

Background: Non fermenting Gram Negative Bacilli arediverse and complex group of bacteria that possess very fewdefined characteristics. They are aerobic, non-fermentingGram negative bacilli which were initially considered ascontaminants but have come up with life threatening infectionsin hospitals as multidrug resistant organisms posing a threatbecause of their inherent and acquired drug resistance nature.Aims: Isolation and identification of NFGNB in clinical samplesand determination of their antibiotic sensitivity profile.Materials and Methods: The study was conducted in theDepartment of Microbiology, RIMS, Ranchi from February2017-July 2017. Various clinical samples reaching theBacteriology section of the Department of Microbiology wereprocessed and NFGNB were isolated and identified usingstandard procedure and their antibiotic susceptibility wasperformed.Results: A total of 3581 samples were received out of which2246 were culture positive and 217 were identified as NFGNB.The isolation rate of NFGNB was 9.6%. Number of malesaffected by NFGNB was 121 and that of females was 96.Analysed by specimen NFGNB were isolated from 91 urine, 74pus, 11 ear swab, 6 sputum, 8 body fluid, 21 blood culture and6 catheter tip samples. Urine was most common specimenaccounting for 42% followed by pus (34%), blood (9%), earswab (5%), body fluid (4%), sputum and catheter tip (3%each).The clinical samples from indoor patients yielded highestpercentage of NFGNB (38%) followed by ICU patients (36%)and outdoor patients (26%). Among the NFGNB isolatedPseudomonaas aeruginosa (51%) was the most commonfollowed by Acinetobacter baumanii (22%), Pseudomonas spp(19%), Acinetobacter spp, Stenotrophomonas maltophila,Burkholderia cepacia (2% each), Ralstonia spp &Sphingobacterium spp (1%). Non fermenters were highlysensitive to Imipenem accounting for 91.5% followed byPiperacillin-tazobactam (71.5%), cefoperazone sulbactam(67.7%) & Amikacin (55.6%) on an average.Conclusion: NFGNB considered being contaminants in thepast have now emerged as important health care associatedinfections. In our setting Imipenem can be used for thepreliminary treatment of infections caused by nonfermenters.As these organisms are important opportunistic andnosocomial pathogens causing infections inimmunocompromised patients, better infection control policiesin our settings and its implementation is a must.

6.
Rev. Soc. Bras. Med. Trop ; 52: e20190243, 2019. tab
Article in English | LILACS | ID: biblio-1020442

ABSTRACT

Abstract INTRODUCTION In recent decades, the prevalence of carbapenem-resistant Acinetobacter isolates has increased, and the production of oxacillinase (OXA)-type carbapenemases is the main mechanism underlying resistance. We evaluated OXA production from 114 Acinetobacter isolates collected between March and December 2013 from different clinical specimens of patients in two hospitals (Hospital 1 [n = 61] and Hospital 2 [n = 53]) located in Niterói, Rio de Janeiro, Brazil. We also evaluated the genetic diversity of OXA-producing isolates. METHODS All the isolates were identified through the automated system Vitek II and matrix-assisted laser desorption ionization-time of flight mass spectrometry MALDI-TOF MS as belonging to the A. baumannii-A. calcoaceticuscomplex. Antimicrobial susceptibility profiles were verified through agar diffusion tests. The presence of OXA-encoding genes was confirmed by PCR. The genetic diversity of isolates positive for carbapenemase production was analyzed through pulsed-field gel electrophoresis. RESULTS There was a high rate of resistance to carbapenems in the isolates (imipenem: 96%; meropenem: 92%) from both hospitals. Moreover, a high percentage (95.6%) of OXA-23-positive isolates was observed for both hospitals, indicating that this was the main mechanism of carbapenem-resistance among the studied population. In addition, most isolates (96.5%) were positive for bla OXA-51. A high genetic diversity and a few major genotypes were found among the OXA-23-positive isolates analyzed. Only intra-hospital dissemination was observed. CONCLUSIONS The elevated dissemination of bla OXA-23-like observed among Acinetobacter isolates from both the studied hospitals highlights the need for continuous epidemiological surveillance in these institutions.


Subject(s)
Humans , Acinetobacter/enzymology , beta-Lactamases/drug effects , Acinetobacter Infections/microbiology , Acinetobacter/drug effects , Acinetobacter/genetics , beta-Lactamases/biosynthesis , Brazil , DNA, Bacterial/genetics , Microbial Sensitivity Tests , Polymerase Chain Reaction , Bacterial Typing Techniques , Electrophoresis, Gel, Pulsed-Field , Hospitals, General , Anti-Bacterial Agents/pharmacology
8.
Acta bioquím. clín. latinoam ; 51(4): 675-680, dic. 2017. tab
Article in Spanish | LILACS | ID: biblio-886150

ABSTRACT

Las infecciones asociadas con el cuidado de la salud son consideradas un problema epidémico, controlable pero difícilmente erradicable. La detección precoz de pacientes colonizados por microorganismos multirresistentes, a través de cultivos de vigilancia epidemiológica y la implementación de medidas preventivas pueden reducir su incidencia. El objetivo del trabajo fue establecer los momentos adecuados durante la hospitalización para realizar estudios de colonización y decidir los microorganismos a estudiar según el lugar de procedencia del paciente. Se analizaron hisopados rectales de pacientes internados en la Unidad de Terapia Intensiva, obtenidos al ingreso, a las 72 h y al sexto día de internación. Se investigó Acinetobacter spp multirresistente (AMR), enterobacterias productoras de BLEE (EB-BLEE) y de KPC (EB-KPC). Los resultados mostraron 15,2% de pacientes de la comunidad y 16,7% de geriátricos colonizados con EB-BLEE al ingreso. Dicho porcentaje fue mayor (28,6%) en pacientes previamente institucionalizados y, además, 2,6% colonizados con EB-KPC y 3,4% con AMR. Los controles posteriores mostraron porcentajes crecientes de portación con el transcurso de la internación. Por lo tanto, es importante la detección de estos microorganismos al ingreso hospitalario y continuar con vigilancia activa, para poder implementar medidas precoces tendientes a evitar las consecuencias de la rápida transmisión horizontal.


Healthcare associated infections are considered an epidemic problem; manageable but difficult to eradicate. The early detection of patients infected with antimicrobial multiresistant microorganisms by means of epidemiological surveillance cultures and the execution of prophylactic measures, are key to reduce their incidence. The aim of this work was to assess a suitable schedule in the course of hospitalisation to perform colonisation studies and to decide which microorganisms to analyse according to the provenance of the patient. Rectal swabs from patients admitted at the Intensive Care Unit obtained at the time of admission, 72 h and six days later were analysed. Multiresistant Acinetobacter spp.(MRA), ESBL- and KPC- producing Enterobacteriaceae (ESBL-EB and KPC-EB, respectively) were investigated. Results showed that 15.2% of patients without previous hospitalisation and 16.7% of patients coming from geriatric institutions were colonised by ESBL-EB at the moment of admission. This percentage was greater (28.6%) in previously hospitalised patients, of whom 2.6% were found to be colonized by KPC-EB and 3.4% by MRA. Subsequent monitoring showed increasing colonisation percentages with the course of hospitalisation. Therefore, detection of these microorganisms at the time of admission and constant active surveillance are crucial to implement early measures aiming to avoid the consequences of rapid horizontal dissemination.


As infecções relacionadas ao cuidado da saúde são consideradas um problema epidêmico controlável, mas dificilmente erradicável. A identificação precoce em pacientes colonizados por microorganismos multirresistentes, através de culturas de vigilância epidemiológica e a implementação de medidas preventivas, podem diminuir sua incidência. O objetivo do trabalho foi estabelecer os momentos adequados durante a hospitalização para realizar testes de colonização e decidir quais os microorganismos que serão estudados de acordo com o lugar de procedência do paciente. Foram testados Swabs retais de pacientes internados na Unidade de Terapia Intensiva (UTI), coletados ao serem admitidos, nas 72h e no sexto dia de internação. Foram analisados Acinetobacter spp. multirresistente (AMR), enterobactérias produtoras de BLEE (EB-BLEE) e de KPC (EB-KPC). Os resultados mostraram 15.2% de pacientes da comunidade e 16.7% de geriátricos colonizados com EB-BLEE ao serem admitidos. Ese percentual foi maior (28.6%) em pacientes previamente institucionalizados e, além disso, 2.6% colonizados com EB-KPC e 3.4% com AMR. Os controles posteriores mostraram percentuais crescentes de portação com o decorrer da internação. Portanto, é importante a identificação destes microorganismos no momento da admissão hospitalar e continuar com a vigilância ativa, para poder implementar medidas precoces tendentes a evitar as consequências da rápida transmissão horizontal.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Colon/microbiology , Early Diagnosis , Epidemiological Monitoring , Patients/statistics & numerical data
9.
São Paulo; s.n; s.n; 2017. 68 p. tab, graf, ilus.
Thesis in Portuguese | LILACS | ID: biblio-846697

ABSTRACT

A resistência bacteriana a antibióticos é um grave e crescente problema de saúde pública de âmbito mundial. O principal, e mais eficiente, mecanismo de resistência aos ß-lactâmicos em bacilos Gram-negativos é a produção de ß-lactamases, que possuem a capacidade de hidrolisar o anel ß-lactâmicos e consequentemente inativar essa classe de antibióticos. Vale ressaltar, que atualmente os antibióticos ß-lactâmicos são os mais utilizados clinicamente, particularmente em infecções graves. Dentre as ß-lactamases existentes destacam-se as carbapenemases, enzimas capazes de inativar a maioria dos antibióticos ß-lactâmicos. Uma grande preocupação é o fato dessas enzimas, em sua maioria, serem codificadas por plasmídeos, o que propicia a disseminação desses genes de resistência; portanto, é de extrema importância a realização de um rápido e efetivo monitoramento da presença de patógenos portadores desses genes de resistência, para que assim se possa prevenir a disseminação desses determinantes. Foram incluídos neste estudo 230 amostras únicas de Acinetobacter e Pseudomonas aeruginosa resistentes a imipenem detectados em pacientes internados em hospitais privados da cidade de São Paulo durante o período de fevereiro a outubro de 2013. As amostras foram avaliadas quanto à hidrólise de imipenem por espectrofotometria, quanto à presença de genes de carbapenemases por PCR e sequenciamento, e quanto à clonalidade por eletroforese em campos pulsados (PFGE) ou ERIC-PCR. Foram realizados ensaios de conjugação, transformação e sequenciamento completo de plasmídeos. Dentre as amostras de Acinetobacter spp. 80% (88) foram capazes de hidrolisar o imipenem. Dentre esses 76,1% (67) foram positivos para blaOXA-51-like, 19,3% (17) foram positivos para blaOXA-72. blaOXA-23, blaOXA-482 e blaIMP-1 foram detectados isoladamente em isolados distintos. O gene blaIMP-1 foi detectado em A. ursingii inserido em integron de classe 1 e representa a primeira descrição no Brasil. Uma nova carbapenemase OXA-482-like foi detectada em A. baumanii. Utilizando-se ERIC-PCR, observou-se uma grande diversidade de grupos clonais, com o máximo de quatro isolados por grupo. Dentre as amostras de P. aeruginosa, apenas 35,3% foram capazes de hidrolisar o imipenem. Dessas amostras, 14 possuíam o gene blaSPM-1, e isolados únicos possuíam, individualmente, os genes blaIMP, blaVIM, blaKPC-2 ou blaGES-23. O gene blaKPC-2 foi detectado inserido em contexto genético diferente dos descritos anteriormente, em plasmídeo IncU de 32 Kb, mobilizável, mas não conjugativo. Esta é a primeira descrição da sequencia completa de plasmídeo albergando o gene blaKPC-2 em P. aeruginosa no Brasil. Nas demais amostras (20) com atividade hidrolítica, não foram detectados genes de carbapenemase conhecidos, o que sugere a presença de genes de carbapenemase ainda não descritos. Em três amostras foi possível obter transformantes com plasmídeos, resistentes a carbapenêmicos. As amostras com blaSPM-1 apresentaram perfis de PFGE estreitamente relacionados. Em contraste, os perfis de PFGE das amostras com potenciais novas carbapenemases apresentaram índice de similaridade de Dice inferior ix a 80%, evidenciando grande diversidade clonal. Nossos achados evidenciam que a carbapenemase não intrínseca predominante em Acinetobacterem hospitais privados da cidade de São Paulo é OXA-72, e em hospitais privados há uma grande diversidade clonal. Em P. aeruginosa, a carbapenemase predominante é SPM-1, cuja disseminação é mediada por um único clone. Há potencialmente um número significativo de novas carbapenemases em Acinetobacter e P. aeruginosa, algumas delas mediadas por plasmídeos


Bacterial resistance to antibiotics is a serious and growing public health problem worldwide. The main and most efficient mechanism of resistance to ß-lactams in Gram-negative bacilli is the production of ß-lactamases, which have the ability to hydrolyze the ß-lactam ring and consequently inactivate this class of antibiotics. It is worth mentioning that currently ß-lactam antibiotics are the most used clinically, particularly in severe infections. Among the existing ß-lactamases, carbapenemases are capable of inactivating most ß-lactam antibiotics. A major concern is that these enzymes are mostly encoded by plasmids, which facilitates the spread of these resistance genes; therefore, it is of extreme importance to carry out a rapid and effective monitoring of the presence of pathogens bearing these resistance genes, in order to prevent the dissemination of these determinants. This study included 230 unique samples of imipenem-resistant Acinetobacterand Pseudomonas aeruginosa detected in patients hospitalized in private hospitals in the city of São Paulo during the period from February to October 2013. The samples were evaluated for the imipenem hydrolysis by spectrophotometry, the presence of carbapenemase genes by PCR and sequencing, and concerning clonality by pulsed field electrophoresis (PFGE) or ERIC-PCR. Conjugation, transformation and complete sequencing of plasmids were performed. Among Acinetobacter spp. samples, 80% (88) were able to hydrolyze imipenem. Among these, 76.1% (67) were positive for blaOXA-51-like genes and 19.3% (17) were positive for blaOXA-72. The blaOXA-23, blaOXA-482 and blaIMP-1 genes were detected alone in distinct isolates. The blaIMP-1 gene was detected in A. ursingii inserted in class 1 integron and represents the first description in Brazil. A novel OXA-482-like carbapenemase was detected in A. baumanii. Using ERIC-PCR, a great diversity of clonal groups was observed, with a maximum of four isolates per group. Among P. aeruginosa samples, only 35.3% were able to hydrolyze imipenem. Of these samples, 14 had the blaSPM-1 gene, and single isolates individually possessed the blaIMP, blaVIM, blaKPC-2 or blaGES-23 genes. The blaKPC-2 gene was found inserted in a genetic context different from those described previously, in a mobilizable, but not conjugative, 32 Kb IncU plasmid. This is the first description of the complete nucleotide sequence of a plasmid harboring the blaKPC-2 gene in P. aeruginosa in Brazil. In the remaining samples (20) with hydrolytic activity, no known carbapenemase genes were detected, suggesting the presence of carbapenemase genes not yet described. In three samples it was possible to obtain transformants with plasmids, resistant to carbapenems. Samples with blaSPM-1 showed closely related PFGE profiles. In contrast, the PFGE profiles of the samples with potential new carbapenemases showed Dice similarity index lower than 80%, evidencing a great clonal diversity. Our findings show that the predominant non-intrinsic carbapenemase in Acinetobacter in the city of São Paulo is OXA-72, and in private hospitals there is great clonal diversity. In P. aeruginosa, the predominant carbapenemase is SPM-1, the spread of this enzyme is mediated by a single clone. There are potentially a significant number of new carbapenemases in Acinetobacter and P. aeruginosa, some of them plasmid mediated


Subject(s)
Acinetobacter/metabolism , Genotype , Phenotype , Pseudomonas aeruginosa/metabolism , Anti-Infective Agents , Carbapenems , Disease Resistance , Gram-Negative Aerobic Bacteria , Plasmids
10.
Braz. J. Pharm. Sci. (Online) ; 53(2): e16111, 2017. tab
Article in English | LILACS | ID: biblio-839487

ABSTRACT

ABSTRACT The present study evaluated the antimicrobial susceptibility profile, ß-lactamase production, and genetic diversity of Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spp. using phenotypic identification, antimicrobial susceptibility testing, and ß-lactamase phenotypic detection. Isolates were obtained from patients in an intensive care unit in a hospital in southern Brazil. Bacterial genomic DNA was extracted, followed by the genotypic detection of carbapenemases and enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR). Fifty-six isolates (26 Klebsiella pneumoniae, five Escherichia coli, three Enterobacter aerogenes, nine P. aeruginosa, and 13 Acinetobacter spp.) were evaluated. The phenotypic extended spectrum ß-lactamase (ESBL) test was positive in 53.8% of the K. pneumoniae isolates, 100.0% of the E. coli isolates, and 100.0% of the E. aerogenes isolates. Phenotypic and genotypic testing of K. pneumoniae carbapenemase (KPC) was positive in 50.0% of the K. pneumoniae isolates. Phenotypic and genotypic testing showed that none of the P. aeruginosa or Acinetobacter spp. isolates were positive for metallo- ß-lactamase (MBL). The bla OXA gene was detected only in Acinetobacter spp. The lowest genetic diversity, determined by ERIC-PCR, was observed among the KPC-producing K. pneumoniae isolates and OXA-producing Acinetobacter spp. isolates, indicating the inadequate dissemination control of multidrug-resistant bacteria in this hospital environment.


Subject(s)
Humans , Male , Female , beta-Lactamases/analysis , Gram-Negative Bacteria/classification , Intensive Care Units/statistics & numerical data , Pseudomonas aeruginosa/metabolism , Acinetobacter/metabolism , Microbiology , Bacterial Typing Techniques/instrumentation , Enterobacteriaceae/metabolism
11.
Indian J Med Microbiol ; 2016 Oct-Dec; 34(4): 513-515
Article in English | IMSEAR | ID: sea-181118

ABSTRACT

With the increasing incidence of multidrug‑resistant organisms, there is a need for newer antibiotics. However, due to the lack of new antimicrobial agents, it is necessary to re‑evaluate the older agents like minocycline which is a second‑line antimicrobial agent. In this study, minocycline susceptibility testing was performed for 693 Escherichia coli, 316 Klebsiella spp. and 89 Acinetobacter spp. Among extended spectrum beta‑lactamase producing E. coli and Klebsiella spp. percentage susceptibility to minocycline were 76 and 85, respectively. Among the carbapenem resistant E. coli, Klebsiella spp. and Acinetobacter spp. minocycline susceptibility were 52%, 55% and 42%, respectively. Based on the susceptibility profile, minocycline can be considered for treatment of infections by multidrug‑resistant organisms.

12.
Asian Pacific Journal of Tropical Medicine ; (12): 903-908, 2016.
Article in Chinese | WPRIM | ID: wpr-951345

ABSTRACT

Objective To identify and to determine the antimicrobial susceptibility of Acinetobacter baumannii (A. baumannii) clinical isolates from ICU at Aseer Central Hospital. Methods The study was conducted in the Intensive Care Unit, Aseer Central Hospital, Saudi Arabia over 13 months period (2014-2015). Acinetobacter species (n = 105) were isolated from various clinical samples. Isolates were identified using selected phenotypic criteria and confirmed using the Vitek 2 automated system. This system was used to determine the susceptibilities of 21 antimicrobial agents. Patients, isolates and drug data were analyzed using the SPSS statistical software package to determine some epidemiological and microbiological patterns. Results Of the 105 stains, A. baumannii accounted for 49 (46.67%), A. baumannii complex, 19 (18.09%), A. baumannii/haemolyticus 32 (30.47), Acinetobacter haemolyticus 4 (3.81%), Acinetobater lwoffii 1 (0.95%) and unidentified Acinetobater species 2 (1.3%). Of the 105 Acinetobacter strains, 103 (98.1%) were found multidrug resistant (MDR). A. baumannii strain were 100% sensitive to colistin and 74.5% to trimethoprim + sulfamethoxazole. The remaining 19 antimicrobial agents revealed low or no sensitivities: amikacin 16.3%; ampicillin 7.7%; ceftazidime, 7.3%. Distribution of similar sensitivities was shown by other Acinetobacter species. Mean number of isolates from males and females indicates no statistical variation (P = 0.867) whereas age groups showed significant differences (P = 0.008) as it is clear from the high percentage of infected individuals more than 60 years followed by those aged 20-29 years old (19.05%). Upper respiratory tract (30.48%), lower respiratory tract (47.65%) and subcutaneous tissue (9.5%) were the main sources of Acinetobacter spp. but mean numbers of isolates from these specimens indicate no discrepancy between specimens (P = 0.731). Conclusions Acinetobacter species including A. baumannii were found MDR (98.1%) according to the current Acinetobacter spp. antimicrobial categorization. Approximately half of these strains were A. baumannii. All Acinetobacter species were 100% sensitive to colistin and to some extent to trimethoprim + sulfamethoxazole (74.5%). ICU-acquired pneumonia among patients over 60 years of age who spend prolong times at artificial ventilations made up the majority of the cases.

13.
Asian Pacific Journal of Tropical Medicine ; (12): 903-908, 2016.
Article in English | WPRIM | ID: wpr-819894

ABSTRACT

OBJECTIVE@#To identify and to determine the antimicrobial susceptibility of Acinetobacter baumannii (A. baumannii) clinical isolates from ICU at Aseer Central Hospital.@*METHODS@#The study was conducted in the Intensive Care Unit, Aseer Central Hospital, Saudi Arabia over 13 months period (2014-2015). Acinetobacter species (n = 105) were isolated from various clinical samples. Isolates were identified using selected phenotypic criteria and confirmed using the Vitek 2 automated system. This system was used to determine the susceptibilities of 21 antimicrobial agents. Patients, isolates and drug data were analyzed using the SPSS statistical software package to determine some epidemiological and microbiological patterns.@*RESULTS@#Of the 105 stains, A. baumannii accounted for 49 (46.67%), A. baumannii complex, 19 (18.09%), A. baumannii/haemolyticus 32 (30.47), Acinetobacter haemolyticus 4 (3.81%), Acinetobater lwoffii 1 (0.95%) and unidentified Acinetobater species 2 (1.3%). Of the 105 Acinetobacter strains, 103 (98.1%) were found multidrug resistant (MDR). A. baumannii strain were 100% sensitive to colistin and 74.5% to trimethoprim + sulfamethoxazole. The remaining 19 antimicrobial agents revealed low or no sensitivities: amikacin 16.3%; ampicillin 7.7%; ceftazidime, 7.3%. Distribution of similar sensitivities was shown by other Acinetobacter species. Mean number of isolates from males and females indicates no statistical variation (P = 0.867) whereas age groups showed significant differences (P = 0.008) as it is clear from the high percentage of infected individuals more than 60 years followed by those aged 20-29 years old (19.05%). Upper respiratory tract (30.48%), lower respiratory tract (47.65%) and subcutaneous tissue (9.5%) were the main sources of Acinetobacter spp. but mean numbers of isolates from these specimens indicate no discrepancy between specimens (P = 0.731).@*CONCLUSIONS@#Acinetobacter species including A. baumannii were found MDR (98.1%) according to the current Acinetobacter spp. antimicrobial categorization. Approximately half of these strains were A. baumannii. All Acinetobacter species were 100% sensitive to colistin and to some extent to trimethoprim + sulfamethoxazole (74.5%). ICU-acquired pneumonia among patients over 60 years of age who spend prolong times at artificial ventilations made up the majority of the cases.

14.
Chinese Journal of Infection Control ; (4): 654-657, 2015.
Article in Chinese | WPRIM | ID: wpr-482230

ABSTRACT

Objective To compare the differences between two statistical methods for evaluating non-sensitivity of pathogenic bacteria to antimicrobial agents,and explore effect of non-consideration of clinical background on evalua-ting extent of bacterial resistance.Methods Data of Staphylococcus aureus and Acinetobacter spp .in a hospital in the first half year of 2008,2010 and 2013 were collected and conducted statistical analysis with two methods (me-thod 1 :based on all clinically isolated bacteria;method 2 :based on infection-related non-repetitive bacteria),two methods for evaluating bacterial non-sensitive rates to antimicrobial agents were compared.Results The non-sensi-tive rates of Acinetobacter spp .to various antimicrobial agents :statistical results by using method 1 were generally higher than those using method 2,absolute difference between two statistical methods was 10.46%-33.77%;the non-sensitive rates of Staphylococcus aureus to various antimicrobial agents :except compound sulfamethoxazole in 2010 and 2013(difference were 6.17% and 10.21 % respectively),penicillin G (difference was 3.86%),erythromy-cin (difference was 2.71 %),and azithromycin in 2013 (difference was 2.43%),statistical results by using method 1 were generally higher than those using method 2,absolute difference between two statistical methods was 0-18.04%.Conclusion There are deviation in the non-sensitive rates of bacterial strains to antimicrobial agents by using two different statistical methods,deviation is larger in Acinetobacter spp ..The resistance level might be incorrectly higher when evaluating the resistance status without considering clinical background of bacteria.

15.
Rev. argent. microbiol ; 46(4): 320-324, dic. 2014.
Article in Spanish | LILACS | ID: biblio-1008535

ABSTRACT

Se analizaron 200 aislamientos de Acinetobacter correspondientes a igual cantidad de pacientes atendidos en el Hospital de Clínicas José de San Martín entre marzo de 2013 y junio de 2014. La identificación se realizó mediante espectrometría de masa y se confirmó con métodos moleculares. La sensibilidad a los antimicrobianos se determinó mediante el sistema Vitek-2. La correlación entre la identificación obtenida con la espectrometría de masa y las técnicas moleculares fue del 94 %. Acinetobacter baumannii multirresistente fue la genoespecie predominante (92,6 %) en la infección intrahospitalaria, y la frecuencia de aislamiento de Acinetobacter pitti y de Acinetobacter nosocomialis fue de 3,5 % y 0,5 %, respectivamente. En la infección extrahospitalaria se observó una mayor presencia de otras genoespecies. Acinetobacter johnsonii y A. baumannii fueron las más frecuentes y juntas representaron el 45,9 % de los hallazgos. La resistencia a carbapenems y a minociclina solo se observó en A. baumannii. La espectrometría de masa resultó ser una herramienta útil en la identificación de las diferentes genoespecies


Two-hundred Acinetobacter isolates belonging to 200 patients admitted to Hospital de Clínicas José de San Martín during the period March 2013-June 2014 were analyzed. The identification was performed by mass spectrometry and was confirmed by molecular methods. Susceptibility to antimicrobials was studied by the Vitek-2 system. A 94% correlation of both identification methods was found. Multidrug resistant Acinetobacter baumannii was the predominant genomic species (92.6%) in hospital-acquired infections, whereas Acinetobacter pitti and Acinetobacter nosocomialis accounted for 3.5% and 0.5% of the isolates recovered, respectively. In community-acquired infections a major predominance of the different genomic species was observed. Acinetobacter johnsonii and A. baumannii are the most frequent species, accounting for 45.9% of the isolates recovered. Resistance to carbapenems and minocycline was only observed in A. baumannii. Mass spectrophotometry was an effective tool for the identification of the different genomic species


Subject(s)
Humans , Male , Female , Drug Resistance, Microbial/drug effects , Acinetobacter baumannii/isolation & purification , Species Specificity , Mass Spectrometry/methods , Acinetobacter Infections/diagnosis , Microbial Sensitivity Tests/statistics & numerical data , Acinetobacter baumannii/drug effects
16.
Rev. cuba. med. trop ; 66(3): 400-414, sep.-dic. 2014.
Article in Spanish | LILACS, CUMED | ID: lil-737009

ABSTRACT

Introducción: Klebsiella pneumoniae y el complejo Acinetobacter baumannii-calcoaceticus constituyen importantes patógenos nosocomiales a nivel mundial siendo más susceptibles los pacientes ingresados en neonatología y unidades de cuidados intensivos. Objetivos: caracterizar, desde el punto de vista clínico-microbiológico los aislamientos de los géneros Klebsiella y Acinetobacter causantes de infecciones en hospitales pediátricos cubanos. Métodos: se realizó un estudio descriptivo-longitudinal durante el período de Junio 2011-Septiembre 2012 que incluyó 152 aislamientos clínicos (102 de Klebsiella spp. y 50 de Acinetobacter spp) causantes de infecciones nosocomiales en niños y que fueron remitidos al Laboratorio Nacional de Referencia de Microbiología del Instituto Pedro Kourí. La identificación de esta especie se realizó mediante pruebas bioquímicas. Se determinó la susceptibilidad a 18 antimicrobianos, la producción de ß;-lactamasas de espectro extendido (BLEE) y la de metalo-ß;-lactamasas (MBLs) según las normas del Instituto de Estandarización de Laboratorio Clínico (CLSI, por sus siglas en inglés). Resultados: las muestras más frecuentes de recuperación de Acinetobacter y Klebsiella fueron sangre, secreción endotraqueal y lesiones de piel. Klebsiella pneumoniae (96 por ciento) y el complejo Acinetobacter baumannii-calcoaceticus (90 por ciento) fueron las especies más prevalentes y se aislaron con mayor frecuencia en servicios de terapias, neonatología y quemado. Ambos patógenos mostraron elevada resistencia a las cefalosporinas con 57 por ciento de producción de BLEE para el género Klebsiella spp. La resistencia a carbapenémicos solo se detectó en Acinetobacter spp (61 por ciento) mediada por la producción de metalo-&-lactamasas en un 2 por ciento de los aislamientos. La mayor susceptibilidad de este género se encontró para las tetraciclinas, mientras que el género Klebsiella spp. fue más susceptible a la ciprofloxacina. En ambos se observó resistencia elevada para los aminoglucósidos (66 por ciento-75 por ciento) y el trimetoprim-sulfametoxazol (45 por ciento-60 por ciento). Conclusiones: Klebsiella pneumoniae y el Complejo Acinetobacter baumannii-calcoaceticus constituyen un peligro potencial en servicios pediátricos con escasas opciones terapéuticas quedando como únicas alternativas los carbapenémicos para las infecciones por Klebsiella spp multidrogorresistentes y la colistina para las infecciones por Acinetobacter spp con extrema drogorresistencia(AU)


Introduction: Klebsiella pneumoniae and the Acinetobacter baumannii-calcoaceticus complex represent important nosocomial pathogens worldwide. The patients admitted to the neonatology and the intensive care unit services suffer infections very frequently. Objectives: to characterize clinically and microbiologically Klebsiella and Acinetobacter isolates causing infections in Cuban pediatric hospitals. Methods: a descriptive longitudinal study of 152 clinical isolates (102 Klebsiella spp and 50 Acinetobacter spp), which caused nosocomial infections in children and were sent to the national reference laboratory of microbiology in Pedro Kouri Institute. The study was conducted from June 2011 to September 2012. The species were identified by biochemical tests. The susceptibility to 18 antimicrobials, the production of extended spectrum ß-lactamase (ESBL) and metallo-ß-lactamases were determined according to the Clinical and Laboratory Standards Institute. Results: the most frequent infections in infants and children by Acinetobacter and Klebsiella were found in blood, endotracheal secretion and skin lesions.. Klebsiella pneumoniae (96 percent) and Acinetobacter baumannii-calcoaceticus complexes (90 percent) were the most prevalent species and were frequently isolated in intensive care, neonatology and burned patient wards. Both pathogens showed high resistance to cephalosporins with 57 percent of extended-spectrum betalactamase production in Klebsiella spp. Resistance to carbapenems was only detected in Acinetobacter (61 percent) with 2 percent of metallobetalactamse production. Acinetobacter spp. was more susceptible to tetracyclines and cholistin where Klebsiella spp was more susceptible to ciprofloxacin. In both pathogens, a high resistance to aminoglycosides (66 percent -75 percent) and trimethoprim-sulfamethoxazole (45 percent-60 percent) was observed. Conclusions: Klebsiella pneumoniae and Acinetobacter baumannii-calcoaceticus complex represent a potential threat in pediatric services with few therapeutic options. The carbapenems remain the only alternative to severe infections caused by multidrug resistant Klebsiella spp and cholistin is the only choice to treat extreme multidrug resistant Acinetobacter spp infections(AU)


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Acinetobacter/isolation & purification , Drug Resistance, Microbial/drug effects , Cross Infection/prevention & control , Laboratory Test/methods , Klebsiella pneumoniae/isolation & purification , Epidemiology, Descriptive , Longitudinal Studies
17.
Sci. med ; 24(2): 150-155, abr-jun. 2014. tab
Article in Portuguese | LILACS-Express | LILACS | ID: lil-742482

ABSTRACT

Objetivos: Avaliar as características de sensibilidade a antimicrobianos de Acinetobacter spp. e Pseudomonas aeruginosa resistentes aos carbapenêmicos, isolados entre agosto de 2011 a janeiro de 2012 de pacientes internados no Hospital Universitário de Santa Maria, na cidadede Santa Maria, Rio Grande do Sul, Brasil.Métodos: Foi realizado um estudo retrospectivo através da consulta ao banco de dados do Laboratório de Microbiologia, onde foram incluídos todos os isolados de Acinetobacter spp. e P. aeruginosa provenientes de diferentes espécimes clínicos coletados de pacientes internados que apresentaram resistência ou perfil intermediário aos antimicrobianos carbapenêmicos de uso neste nosocômio (imipenem, meropenem e ertapenem) verificados através de metodologia convencional pela técnica de difusão do disco (Kirby-Bauer) ou metodologia automatizada (MicroScan® ? Siemens) de acordo com as normas preconizadas pelo Clinical and Laboratory Standards Institute.Resultados: No período estudado foram encontradas 58 amostras de bacilos Gram-negativos não fermentadores resistentes aos carbapenêmicos, sendo 32 do gênero Acinetobacter e 26 P. aeruginosa. Acinetobacter spp. foi mais isolado na Unidade de Tratamento Intensivo, enquanto P. aeruginosa prevaleceu no Pronto Atendimento e no Ambulatório. Ambos os microrganismos provieram principalmente de secreções respiratórias.Conclusões: Neste estudo Acinetobacter spp. e P. aeruginosa apresentaram elevada resistência aos antimicrobianos. A polimixina B mostrou-se um bom antimicrobiano para o tratamento de infecções por microrganismos resistentes aos carbapenêmicos neste nosocômio.


Aims: To evaluate the characteristics of antimicrobial susceptibility of carbapenem-resistant Acinetobacter spp. and Pseudomonas aeruginosaisolated from August 2011 to January 2012 from inpatients at the University Hospital of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.Methods: A retrospective study was conducted by consulting the database of the Microbiology Laboratory, which included all isolates ofAcinetobacter spp. and P. aeruginosa from different clinical specimens collected from hospitalized patients who had resistant or intermediate profile to carbapenemic antimicrobials used in this hospital (imipenem, meropenem and ertapenem) verified through conventional methodologyby disc diffusion (Kirby-Bauer) or automated method (MicroScan® ? Siemens) according to the standards recommended by the Clinical andLaboratory Standards Institute.Results: In the studied period 58 samples of nonfermenters Gram-negative bacilli resistant to carbapenems were found, 32 of the genus Acinetobacter and 26 of P. aeruginosa. Acinetobacter spp. was more isolated in the intensive care unit, while P. aeruginosa prevailed in the emergency and outpatient departments. Both microorganisms came mainly from respiratory secretions.Conclusions: In this study, Acinetobacter spp. and P. aeruginosa showed high antimicrobial resistance. Polymyxin B was a good antimicrobial for the treatment of infections caused by microorganisms resistant to carbapenems in this hospital.

18.
Braz. j. microbiol ; 45(2): 495-501, Apr.-June 2014. graf, tab
Article in English | LILACS | ID: lil-723105

ABSTRACT

P. aeruginosa and Acinetobacter spp. are important pathogens associated with late nosocomial pneumonia in hospitalized and institutionalized individuals. The oral cavity may be a major source of these respiratory pathogens, particularly in the presence of poor oral hygiene and periodontal infection. This study investigated the prevalence of P. aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with periodontal disease or health. Samples were obtained from 55 periodontally healthy (PH) and 169 chronic periodontitis (CP) patients. DNA was obtained from the samples and detection of P. aeruginosa and Acinetobacter spp. was carried out by multiplex and nested PCR. P. aeruginosa and Acinetobacter spp. were detected in 40% and 45% of all samples, respectively. No significant differences in the distribution of these microorganisms between men and women, subgingival biofilm and saliva samples, patients < 35 and > 35 years of age, and smokers and non-smokers were observed regardless periodontal status (p > 0.05). In contrast, the frequencies of P. aeruginosa and Acinetobacter spp. in saliva and biofilm samples were significantly greater in CP than PH patients (p < 0.01). Smokers presenting P. aeruginosa and high frequencies of supragingival plaque were more likely to present CP than PH. P. aeruginosa and Acinetobacter spp. are frequently detected in the oral microbiota of CP. Poor oral hygiene, smoking and the presence of P. aeruginosa are strongly associated with periodontitis.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Young Adult , Acinetobacter/isolation & purification , Biofilms/growth & development , Gingiva/microbiology , Healthy Volunteers , Periodontal Diseases/microbiology , Pseudomonas aeruginosa/isolation & purification , Saliva/microbiology , Acinetobacter/physiology , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Polymerase Chain Reaction , Prevalence , Pseudomonas aeruginosa/physiology
19.
Annals of Laboratory Medicine ; : 293-299, 2014.
Article in English | WPRIM | ID: wpr-112276

ABSTRACT

BACKGROUND: Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods. METHODS: Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing. RESULTS: Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI(MP-1)-bla(OXA-2)), 3.0-kb type C (bla(VIM-2)-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla(OXA-2)-orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria. CONCLUSIONS: Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.


Subject(s)
Humans , Acinetobacter/drug effects , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/pharmacology , DNA, Bacterial/chemistry , Drug Resistance, Multiple, Bacterial , Integrons/genetics , Microbial Sensitivity Tests , Multilocus Sequence Typing , Polymerase Chain Reaction , Republic of Korea
20.
Korean Journal of Nosocomial Infection Control ; : 29-36, 2014.
Article in Korean | WPRIM | ID: wpr-197848

ABSTRACT

BACKGROUND: In general, higher resistance rates are observed among intensive care unit (ICU) isolates than non-ICU isolates. In this study, resistance rates of isolates from ICUs and non-ICUs were compared using the data generated from 20 hospitals in Korea. METHODS: Susceptibility data were collected from 20 hospitals participating in the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) program. Duplicate isolates were excluded from the analysis. The resistance rates did not include intermediate susceptibility. RESULTS: The most prevalent bacteria in the ICUs were Staphylococcus aureus (21%) and Acinetobacter spp. (19%), and those in non-ICU were Escherichia coli (27%) and S. aureus (14%). The resistance rates were higher in ICUs than in non-ICUs at 84% and 58% for methicillin-resistant S. aureus, 86% and 70% for methicillin-resistant coagulase-negative Staphylcoccus (CNS), 34% and 19% for vancomycin-resistant Enterococcus faecium, 38% and 19% for cefotaxime-resistant E. coli, 45% and 25% for cefotaxime-resistant Klebsiella pneumoniae, 42% and 24% for ceftazidime-resistant Enterobacter cloacae, 29% and 11% for ceftazidime-resistant Serattia marcescens, 83% and 44% for imipenem-resistant Acinetobacter spp., and 32% and 17% for imipenem-resistant Pseudomonas aeruginosa, respectively. CONCLUSION: The most prevalent bacteria in ICUs were S. aureus, CNS, and Acinetobacter spp., and high multi-drug resistance rates were observed in the Acinetobacter isolates. Therefore, infection control should be practiced in ICUs to prevent infections caused by multi-drug resistant bacteria.


Subject(s)
Acinetobacter , Bacteria , Drug Resistance, Multiple , Enterobacter cloacae , Enterococcus faecium , Escherichia coli , Infection Control , Intensive Care Units , Klebsiella pneumoniae , Korea , Methicillin Resistance , Pseudomonas aeruginosa , Staphylococcus aureus
SELECTION OF CITATIONS
SEARCH DETAIL